Do Pharmacogenomic Tests Provide Value to Policy Makers?

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.24, Iss.12, 2006-01, pp. : 1173-1177

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

QALYs: Are They Helpful to Decision Makers?

By McGregor Maurice

PharmacoEconomics, Vol. 24, Iss. 10, 2006-01 ,pp. : 947-952

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness League Tables: Valuable Guidance for Decision Makers?

By Mauskopf J.

PharmacoEconomics, Vol. 21, Iss. 14, 2003-01 ,pp. : 991-1000

Adis International

Access to resources Recommend Favorite

A Systematic Review of Economic Evaluation Literature in Thailand: Are the Data Good Enough to be Used by Policy-Makers?

By Teerawattananon Yot

PharmacoEconomics, Vol. 25, Iss. 6, 2007-01 ,pp. : 467-479

Adis International

Access to resources Recommend Favorite

Open-Label Extension Studies: Do They Provide Meaningful Information on the Safety of New Drugs?

By Day Richard O. Williams Kenneth M.

Drug Safety, Vol. 30, Iss. 2, 2007-01 ,pp. : 93-105

Adis International

Access to resources Recommend Favorite

Current IQWiG guidelines do not provide an "appropriate foundation for informing German decision makers about the value of a health technology,"

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 573, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite